Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity

v3.20.1
Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Series A Preferred Stock [Member]
Common Stock [Member]
Common Shares Issuable [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Non-Controlling Interests [Member]
Total
Balance at Dec. 31, 2017 $ 1 $ 51 $ 500 $ 364,148 $ (312,127) $ 67,929 $ 120,502
Balance (in shares) at Dec. 31, 2017 1,000,000 50,991,285          
Stock-based compensation expense $ 0 $ 0 0 15,012 0 0 15,012
Settlement of restricted stock units into common stock 0 $ 3 0 (3) 0 0 0
Settlement of restricted stock units into common stock (in shares)   2,601,701          
Issuance of common stock under ESPP 0 $ 0 0 198 0 0 198
Issuance of common stock under ESPP (in shares)   110,856          
Issuance of subsidiaries' common shares for license expenses 0 $ 0 164 112 0 0 276
Partner company's offering, net 0 0 0 22,668 0 0 22,668
Partner company's at-the-market offering, net 0 0 0 7,747 0 0 7,747
Exercise of partner company's warrants for cash 0 0 0 181 0 0 181
Issuance of common stock for at-the-market offering, net 0 $ 3 0 7,014 0 0 7,017
Issuance of common stock for at-the-market offering, net (in shares)   2,914,410          
Contribution of capital for 2017 bonuses 0 $ 0 0 1,000 0 0 1,000
Common shares issuable for 2017 Subordinated Note Financing interest expense 0 0 495 0 0 0 495
Common shares issued for 2017 Subordinated Note Financing interest expense 0 $ 1 (500) 1,971 0 0 1,472
Common shares issued for 2017 Subordinated Note Financing interest expense (in shares)   783,965          
Preferred A dividends declared and paid 0 $ 0 0 (2,344) 0 0 (2,344)
2017 Preferred A offering cost adjustment 0 0 0 154 0 0 154
Disposal of National 0 0 0 2,247 0 (15,805) (13,558)
Non-controlling interest in subsidiaries 0 0 0 (23,556) 0 23,556 0
Issuance of partner company warrants in conjunction with Horizon Notes             0
Common shares issued for Opus interest expense 0 $ 0 0 859 0 0 859
Common shares issued for Opus interest expense (in shares)   443,230          
Common shares issued for Opus debt             0
Net loss attributable to non-controlling interest 0 $ 0 0 0 0 (57,789) (57,789)
Net loss attributable to common stockholders 0 0 0 0 (84,147) 0 (84,147)
Balance at Dec. 31, 2018 $ 1 $ 58 659 397,408 (396,274) 17,891 19,743
Balance (in shares) at Dec. 31, 2018 1,000,000 57,845,447          
Stock-based compensation expense $ 0 $ 0 0 13,188 0 0 13,188
Settlement of restricted stock units into common stock 0 $ 2 0 (2) 0 0 0
Settlement of restricted stock units into common stock (in shares)   1,905,367          
Issuance of common stock under ESPP 0 $ 0 0 123 0 0 123
Issuance of common stock under ESPP (in shares)   98,007          
Issuance of subsidiaries' common shares for license expenses 0 $ 0 (164) 164 0 0 0
Partner company's offering, net 0 0 0 78,607 0 0 78,607
Partner company's at-the-market offering, net 0 0 0 29,785 0 0 29,785
Issuance of common stock for at-the-market offering, net 0 $ 12 0 20,235 0 0 20,247
Issuance of common stock for at-the-market offering, net (in shares)   11,798,468          
Issuance of preferred A for at-the-market offering, net $ 0 $ 0 0 788 0 0 788
Issuance of preferred A for at-the-market offering, net (in shares) 39,292            
Issuance of Series A preferred stock for cash, net $ 0 0 0 5,307 0 0 5,307
Issuance of Series A preferred stock for cash, net (in shares) 301,875            
Common shares issuable for 2017 Subordinated Note Financing interest expense $ 0 0 500 0 0 0 500
Common shares issued for 2017 Subordinated Note Financing interest expense 0 $ 2 (495) 1,967 0 0 1,474
Common shares issued for 2017 Subordinated Note Financing interest expense (in shares)   1,637,936          
Common shares issuable for Opus interest expense 0 $ 0 281 0 0 0 281
Preferred A dividends declared and paid 0 0 0 (2,559) 0 0 (2,559)
Non-controlling interest in subsidiaries 0 0 0 (85,277) 0 85,277 0
Issuance of partner companies' common shares for research and development expenses 0 0 0 90 0 0 90
Issuance of partner company warrants in conjunction with Horizon Notes 0 0 0 888 0 0 888
Common shares issued for Opus interest expense 0 $ 0 (281) 662 0 0 381
Common shares issued for Opus interest expense (in shares)   345,375          
Common shares issued for Opus debt 0 $ 0 0 500 0 0 500
Common shares issued for Opus debt (in shares)   396,825          
Deconsolidation of Caelum non-controlling interest 0 $ 0 0 0 0 4,849 4,849
Net loss attributable to non-controlling interest 0 0 0 0 0 (61,700) (61,700)
Net loss attributable to common stockholders 0 0 0 0 (39,960) 0 (39,960)
Balance at Dec. 31, 2019 $ 1 $ 74 $ 500 $ 461,874 $ (436,234) $ 46,317 $ 72,532
Balance (in shares) at Dec. 31, 2019 1,341,167 74,027,425